Opko Health Inc. (OPK) CEO Purchases $202,000.00 in Stock

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 100,000 shares of the firm’s stock in a transaction on Thursday, May 16th. The stock was acquired at an average price of $2.02 per share, for a total transaction of $202,000.00. Following the transaction, the chief executive officer now owns 3,068,951 shares of the company’s stock, valued at approximately $6,199,281.02. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s):

  • On Monday, May 13th, Phillip Md Et Al Frost purchased 200,000 shares of Opko Health stock. The stock was acquired at an average price of $1.99 per share, for a total transaction of $398,000.00.
  • On Friday, May 10th, Phillip Md Et Al Frost purchased 70,000 shares of Opko Health stock. The stock was acquired at an average price of $2.08 per share, for a total transaction of $145,600.00.
  • On Wednesday, May 8th, Phillip Md Et Al Frost purchased 907,000 shares of Opko Health stock. The stock was acquired at an average price of $2.11 per share, for a total transaction of $1,913,770.00.
  • On Monday, April 22nd, Phillip Md Et Al Frost purchased 80,000 shares of Opko Health stock. The stock was acquired at an average price of $2.32 per share, for a total transaction of $185,600.00.
  • On Wednesday, April 17th, Phillip Md Et Al Frost purchased 50,000 shares of Opko Health stock. The stock was acquired at an average price of $2.42 per share, for a total transaction of $121,000.00.
  • On Monday, April 15th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The stock was acquired at an average price of $2.47 per share, for a total transaction of $24,700.00.
  • On Thursday, April 11th, Phillip Md Et Al Frost purchased 30,000 shares of Opko Health stock. The stock was acquired at an average price of $2.49 per share, for a total transaction of $74,700.00.
  • On Tuesday, April 9th, Phillip Md Et Al Frost purchased 10,000 shares of Opko Health stock. The stock was acquired at an average price of $2.51 per share, for a total transaction of $25,100.00.
  • On Thursday, April 4th, Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock. The stock was acquired at an average price of $2.53 per share, for a total transaction of $50,600.00.
  • On Monday, April 1st, Phillip Md Et Al Frost purchased 20,000 shares of Opko Health stock. The stock was acquired at an average price of $2.58 per share, for a total transaction of $51,600.00.

Opko Health stock traded up $0.02 during midday trading on Friday, reaching $2.05. The stock had a trading volume of 4,359,369 shares, compared to its average volume of 5,351,080. Opko Health Inc. has a twelve month low of $1.92 and a twelve month high of $6.40. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.99 and a current ratio of 1.10. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of -8.20 and a beta of 1.81.

Opko Health (NASDAQ:OPK) last posted its quarterly earnings data on Tuesday, May 7th. The biotechnology company reported ($0.14) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.08). Opko Health had a negative return on equity of 9.86% and a negative net margin of 19.92%. The firm had revenue of $222.50 million during the quarter, compared to analyst estimates of $241.27 million. During the same period in the prior year, the business posted ($0.08) EPS. The company’s revenue for the quarter was down 12.7% on a year-over-year basis. Equities analysts forecast that Opko Health Inc. will post -0.42 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. Diversified Trust Co acquired a new position in Opko Health in the 4th quarter worth approximately $30,000. Piedmont Investment Advisors Inc. acquired a new position in Opko Health in the 1st quarter worth approximately $27,000. FDx Advisors Inc. acquired a new position in Opko Health in the 4th quarter worth approximately $33,000. Mercer Global Advisors Inc. ADV acquired a new position in Opko Health in the 1st quarter worth approximately $39,000. Finally, Meeder Asset Management Inc. boosted its stake in Opko Health by 58.7% in the 1st quarter. Meeder Asset Management Inc. now owns 13,102 shares of the biotechnology company’s stock worth $35,000 after purchasing an additional 4,846 shares during the period. 22.64% of the stock is owned by hedge funds and other institutional investors.

Several research firms have issued reports on OPK. ValuEngine lowered shares of Opko Health from a “hold” rating to a “sell” rating in a research report on Wednesday, May 1st. Zacks Investment Research lowered shares of Opko Health from a “hold” rating to a “sell” rating in a research report on Friday, March 8th. Finally, Barrington Research restated a “buy” rating and issued a $5.00 price target on shares of Opko Health in a research report on Thursday, February 28th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. Opko Health presently has a consensus rating of “Buy” and a consensus target price of $9.25.

COPYRIGHT VIOLATION NOTICE: “Opko Health Inc. (OPK) CEO Purchases $202,000.00 in Stock” was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/05/18/opko-health-inc-opk-ceo-purchases-202000-00-in-stock.html.

Opko Health Company Profile

OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.

See Also: Cost of Capital

Insider Buying and Selling by Quarter for Opko Health (NASDAQ:OPK)

Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.